Researchers used parallel PET/MR imaging to map chemotherapy distribution before surgery, improving risk stratification and patient management. This study suggests simultaneous PET/MR imaging can benefit patients by predicting cancer recurrence and avoiding unnecessary chemotherapy.
A new hybrid molecular imaging system combines positron emission tomography and magnetic resonance to detect recurrent prostate cancer. The study reveals that PET/MR finds more areas of metastases than PET/CT, making it a viable alternative for restaging patients with metastatic prostate cancer.
A multi-institutional registry study involving 450 patients found that PRRT treatment significantly prolonged overall survival, with median progression-free survival of up to 51 months. Patients with pancreatic tumors survived an average of 39 months without disease progression.
Researchers developed a new dual agent scan that can differentiate between diabetic foot infection and a non-infectious complication in nerve-damaged joints. The technique combines agents targeting bone cell activity and immune response, allowing doctors to accurately diagnose and rule out unnecessary scans.
Research published in The Journal of Nuclear Medicine found that highly educated pre-Alzheimer's patients exhibit increased neural reserve and compensation, leading to better coping mechanisms. This suggests that education level plays a crucial role in determining cognitive reserve against the disease.
Researchers demonstrated PET/CT's ability to identify lesions along the complete intestinal wall, detecting advanced inflammatory changes and unmasking subepithelial disease activity. The technique showed promise in serially assessing IBD activity, potentially benefiting patients with chronic-remittent conditions.
A new nuclear medicine technique can detect early changes to the lung caused by cigarette smoke exposure, providing a noninvasive method for studying lung dysfunction in preclinical models. This technique has the potential to be applied clinically to study and diagnose the early stages of COPD.
Two novel radiolabeled small molecules targeting PSMA have excellent potential for diagnosing and staging prostate cancer. The imaging agents showed a high sensitivity of lesion detection in bone, soft tissue, and the prostate gland.
A new PET test using 11C-PIB offers a non-invasive method to visualize amyloid deposits in the heart, providing valuable information for disease prognosis and treatment monitoring. The study demonstrated positive uptake of 11C-PIB in patients with cardiac amyloidosis.
The Society of Nuclear Medicine and Molecular Imaging has published the first guidelines for brain amyloid imaging in Alzheimer's disease, providing a framework for healthcare practitioners to determine when to order this test. The guidelines emphasize that amyloid PET imaging should be used judiciously, particularly among elderly indi...
New research reveals that 18F-FDG PET/CT provides better prognostic information than conventional imaging, changing management for over 50% of patients. The study found that PET/CT accurately identified lesions in multiple areas, leading to revised staging and treatment plans.
Researchers used PET imaging to evaluate tumor grade and cellular proliferation in patients with gliomas. The study found that F-18-FLT PET provided a more comprehensive view of tumor grade and correlated with overall survival, making it a valuable tool for guiding treatment.
Researchers used PET scans to visualize the effect of caffeine on brain adenosine receptors for the first time. The study found that up to 50% of A1 adenosine receptors were occupied by caffeine in regular coffee drinkers, suggesting a potential link to neurodegenerative diseases.
Researchers have discovered a new PET imaging agent that can predict the early response to treatment for head and neck cancer patients. The agent, 3'-deoxy-3'F-18-fluorothymidine (18-F-FLT), showed high accuracy in detecting therapeutic responses and identifying patients needing close follow-up.
Researchers found that high F-18-FDG uptake in axillary lymph nodes before treatment can predict disease-free survival in invasive ductal breast cancer patients. A nodal SUVmax of 2.8 was identified as the optimal cutoff for predicting disease-free survival.
Researchers used 99mTc-HMPAO-WBC SPECT/CT to diagnose infectious endocarditis in hard-to-diagnose cases, achieving high sensitivity and specificity. The test detected septic embolism in 41% of patients, aiding physicians in diagnosis and treatment.
A study published in The Journal of Nuclear Medicine found that imaging progesterone receptor (PR) status can identify responders and nonresponders to endocrine therapy in early stages. PR imaging with F-18-FFNP PET may help distinguish between patients who will benefit from hormone-based therapies.
A new vaccine against cocaine addiction uses the body's own immune system to prevent the high, as demonstrated by a molecular imaging technique. The vaccine, called dAd5GNE, combines a cocaine-like molecule with part of the common cold virus, inducing antibodies that bind cocaine in blood and prevent it from entering the brain.
Researchers develop a molecular imaging tool to detect coronary artery disease, which is caused by atherosclerosis. The technique measures the coronary flow reserve, or CFR, and calculates precise dilation of blood vessels at rest and under stress.
A new molecular imaging method using PET/CT with Gallium-68 DOTATATE identifies hormonally active tissues, allowing clinicians to re-evaluate patient management. This technique changes treatment plans in over 35% of patients, saving them from unnecessary surgeries.
A customized patch treatment for basal cell carcinoma has shown an 80% cure rate without surgery or major radiation therapy. The phosphorus-32 skin patch delivers a fragmented dose of radiation to cancerous lesions, killing facial tumors in patients with facial basal cell carcinoma.
A study using PET/CT imaging with F-18 FDG reveals that molecular imaging biomarkers can predict the effectiveness of radiochemotherapy for locally advanced rectal cancer. This improvement in treatment planning could lead to more effective and cost-efficient care.
A molecular imaging study shows that ASV can improve cardiac function, exercise capacity, and sympathetic nerve activity in patients with congestive heart failure. The therapy was found to be just as effective as conservative treatments in reducing symptoms and improving overall health.
A study using molecular imaging found a link between low dopamine levels and aggressive behavior in competitive situations. Participants with lower dopamine synthesis capacity were more likely to act out with aggression when provoked.
A new study reveals that a combination of molecular imaging, radiography, and dual imaging probes detects more cancerous bone lesions than other methods. The addition of molecular imaging with combined radiopharmaceuticals to conventional CT improves the power of imaging for cancer diagnosis.
A new method of 4D PET image reconstruction provides sharper-than-ever images of cardiac function, allowing physicians to pinpoint heart defects for better diagnoses. The technique compensates for blurring caused by the beating of the heart, improving imaging contrast and signal-to-noise ratio.
A study by the Society of Nuclear Medicine found that most patients with differentiated thyroid cancer have excellent survival rates, similar to those without the disease. The majority of patients with early-stage thyroid cancer can live a long and healthy life, thanks to advancements in diagnostic and therapeutic strategies.
Researchers have made significant breakthroughs in Alzheimer's disease detection using molecular imaging technology, which can identify beta-amyloid plaques in the brain. Studies show that high levels of amyloid binding are associated with an 80% chance of developing Alzheimer's disease within two years.
Researchers used bioluminescence imaging to track hair follicle stem cells in mice, showing successful regeneration of new hair follicles. The study paves the way for future clinical trials to test the efficacy of this novel therapy for human hair regeneration.
A new treatment protocol for kidney cancer uses molecular imaging and radioimmunotherapy to target clear cell renal carcinoma. The study found that the effectiveness of this therapy may be diminished when used after another anti-cancer drug, sorafenib.
A new PET imaging technique using an amino acid probe can predict the effectiveness of brain cancer treatment as early as two weeks after initiation, without requiring invasive biopsies. This method provides vital information about the body's response to therapy and has shown promising results in patients with aggressive glioma tumors.
A new line of radioisotope therapy, Radium-223 chloride, has been shown to extend the lives of prostate cancer patients with advanced tumors that have spread to bone. The treatment has a short range of penetration and is usually well-tolerated, with serious side effects being rare.
Research finds that combining molecular imaging with computed tomography (CT) can reduce patient radiation dose. By using just one CT scan for multiple PET studies, researchers lower radiation exposure and improve image quality.
Research shows that PET/CT imaging can change management plans for 34% of esophageal cancer patients, leading to improved survival rates. The technique provides powerful prognostic stratification and should be incorporated into routine clinical practice.
SPECT/CT scans have been shown to change clinical management in thyroid cancer patients by improving staging and risk stratification. The technology has been used both post-operatively and pre-ablation to identify metastatic lesions and adjust treatment approaches, leading to avoidance of unnecessary therapy.
Research reveals that systemic inflammation causes an increase in depressive symptoms and metabolic changes in the brain's mood-regulating regions. This finding opens doors for testing potential treatments for depression in patients experiencing inflammatory-related symptoms.
Imaging amino acid transporters with PET/CT has significantly altered management plans for 41% of patients with brain tumors, according to research. The imaging modality has improved detection of primary and recurrent high- and low-grade brain tumors, leading to changes in treatment from 'watch and wait' to chemotherapy or vice versa.
Researchers use molecular imaging to improve diagnosis and treatment decisions for estrogen-receptor positive breast cancer patients, detecting bone metastases and predicting therapy response. PET imaging with 18F-FES and 18F-FDG improves diagnostic information and prompts changes in treatment for 88% and 48% of subjects respectively.
A new review of imaging studies confirms that positron emission tomography (PET) safely and accurately detects dementia, including the most common form among the elderly, Alzheimer's disease. The study found that combining PET with a biomarker called 18F-FDG can pinpoint key areas of metabolic decline in the brain indicating dementia.
A new PET technique using FLT-PET has shown highly sensitive imaging for patients with mantle cell lymphoma, a relatively rare and devastating blood cancer. The study found that all cancerous lesions were very highly visible using FLT-PET, providing a powerful biomarker for MCL.
Research shows that repeated administrations of radionuclide therapy with 188Re-HEDP improve overall survival rates, reducing pain in prostate cancer patients with hormone-refractory bone metastases. The study found significant increases in post-treatment survival for patients receiving two or three therapies.
Researchers have developed a virtual fly-through 3D imaging technique that accurately detects regional lymph node metastases in non-small cell lung cancer patients. The method achieved an 81% diagnostic accuracy rate, making it a promising tool for non-invasive diagnosis.
Radionuclide therapy (PRRT) with [177Lu-DOTA0,Tyr3]Octreotate has been shown to improve quality of life and reduce tumor size in patients with gastroenteropancreatic or bronchial neuroendocrine tumors. The treatment has been found to have fewer severe side effects compared to other cancer therapies.
The studies focus on positron emission tomography (PET) to differentiate between types of dementia and identify pharmaceuticals to slow dementia progression. PET scores provide a valid biomarker for monitoring Alzheimer's disease progression.
Researchers have found a new treatment option for children with relapsed or primary refractory high-risk neuroblastoma, using combined positron emission tomography and X-ray computed tomography to select patients for molecular radiotherapy. The therapy was well-tolerated and showed promise in improving symptoms and quality of life.
A study introduced at SNM's 58th Annual Meeting found that 4D PET imaging using state-of-the-art image reconstruction and motion correction significantly improves cancer detection. This method provides clearer images, especially for small lesions, allowing for more accurate diagnosis and better treatment planning.
Researchers use molecular imaging to gauge heart efficiency in subjects with a pathogenic mutation linked to HCM. They find carriers of the mutation already have less efficient hearts despite the absence of any symptoms. Alcohol septal ablation is shown to be an effective treatment for symptomatic patients who remain symptomatic despit...
Researchers developed a novel form of radioimmunotherapy that targets antigens associated with renal cell carcinoma. Patients receiving up to three doses show dramatic slowing of cancer growth and stabilization of their disease. The therapy, Lu-177-cG250, targets kidney tumors with high effectiveness for reducing cancer proliferation.
Researchers develop a new therapy to prime tumors before radiotherapy, reducing damage to healthy tissue. The treatment shows effective targeting of tumors with minimal side effects.
The study presents promising results for the clinical use of a new integrated PET/MRI system, which provides diagnostic information on soft tissues and physiological functions. The technology has been shown to be comparable in detecting cancerous tumors as conventional PET/CT methods.